Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Yoga for Symptoms of Nerve Damage Caused by Chemotherapy

Not Applicable

Completed

Conditions: Peripheral Neuropathy
Gynecologic Cancer
Breast Cancer

Interventions: Other: Wait List Control
Other: Yoga

First Posted Date: 2017-09-25

Last Posted Date: 2020-09-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT03292328

Locations: 🇺🇸
Memoral Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States

A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Phase 4

Completed

Conditions: Neuroendocrine Tumors

Interventions: Drug: Octreotide
Drug: LAR Lanreotide
Behavioral: Questionnaires

First Posted Date: 2017-09-21

Last Posted Date: 2023-11-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 53

Registration Number: NCT03289741

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States

and more 4 locations

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Procedure: MRI Biopsy

First Posted Date: 2017-09-20

Last Posted Date: 2024-11-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 31

Registration Number: NCT03289195

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack, New York, United States

and more 4 locations

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

Not Applicable

Active, not recruiting

Conditions: Endometrial Cancer

Interventions: Other: Ketogenic Diet (KD)
Other: Standard Diet (SD)

First Posted Date: 2017-09-15

Last Posted Date: 2024-10-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT03285152

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Consent and follow-up only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and Follow up), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up), Commack, New York, United States

and more 5 locations

A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Phase 2

Active, not recruiting

Conditions: SARCOMA

Interventions: Drug: NKTR-214
Drug: Nivolumab

First Posted Date: 2017-09-13

Last Posted Date: 2024-05-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 88

Registration Number: NCT03282344

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort), New York, New York, United States
🇺🇸
MD Anderson Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort), Houston, Texas, United States

Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Completed

Conditions: Multiple Myeloma

Interventions: Diagnostic Test: Oral microbiota assessment
Diagnostic Test: Comprehensive chemical gustometry
Diagnostic Test: Measurement of salivary flow
Behavioral: Surveys assessing taste disturbances

First Posted Date: 2017-09-08

Last Posted Date: 2023-07-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 47

Registration Number: NCT03276481

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages

Phase 2

Completed

Conditions: Paranasal Sinus Cancer
Nasal Cavity Tumor
Nasal Cavity Adenocarcinoma

Interventions: Drug: Cisplatin
Radiation: Adjuvant Proton Radiotherapy
Procedure: Endoscopic Resection
Drug: cisplatin and etoposide

First Posted Date: 2017-09-07

Last Posted Date: 2023-10-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT03274414

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memoral Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 2 locations

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Phase 3

Active, not recruiting

Conditions: Pancreas Cancer
Pancreatic Diseases
Pancreatic Cancer

Interventions: Drug: Cefoxitin
Drug: Piperacillin-tazobactam

First Posted Date: 2017-09-01

Last Posted Date: 2024-10-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 962

Registration Number: NCT03269994

Locations: 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Hackensack Meridian Health / Hackensack University Medical Center Cancer Center, Hackensack, New Jersey, United States

and more 29 locations

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Phase 1

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: MR-based image-guided, intensity-modulated radiotherapy

First Posted Date: 2017-08-31

Last Posted Date: 2023-09-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT03269422

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only and follow up), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 4 locations

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Not Applicable

Recruiting

Conditions: Locally Advanced Breast Cancer
Breast Cancer

Interventions: Procedure: Sentinel Lymph Node Biopsy (SLNB)

First Posted Date: 2017-08-21

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 150

Registration Number: NCT03255577

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only and Follow Up), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 5 locations

Home Terms & Conditions Privacy Policy